Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 187 results for "wallachbeth capital llc"

WallachBeth Capital Cuts Impax Laboratories Inc. (IPXL) Price ...

Impax Laboratories Inc. (NASDAQ:IPXL) A number of other brokerages also recently issued reports on IPXL. Zacks Investment Research downgraded shares of Impax Laboratories from a hold rating to a strong sell rating in a research report on Tuesday, ... American Banking News - Forex, 2 weeks ago
American Banking News

Esperion Therapeutics Inc. (ESPR) Rating Lowered to Hold at WallachBeth Capital

WallachBeth Capital lowered shares of Esperion Therapeutics Inc. (NASDAQ:ESPR) Shares of Esperion Therapeutics (NASDAQ:ESPR) traded down 1.3289% during trading on Tuesday, reaching $11.0413. The company's stock had a trading volume of 258,178 ...
 Mideast Time1 month ago Esperion Therapeutics Inc. (ESPR) Shares Bought by A.R.T. Advisors LLC  Mideast Time1 month ago Esperion Therapeutics Inc. (ESPR) Downgraded to Hold at WallachBeth Capital  American Banking News - Stock Ratings1 month ago WallachBeth Capital Lowers Esperion Therapeutics Inc. (ESPR) to Hold  WKRB News1 month ago

Akorn Inc. (AKRX) Price Target Raised to $40.00 at WallachBeth Capital

Akorn Inc. (NASDAQ:AKRX) had its price target raised by WallachBeth Capital from $39.00 to $40.00 in a research report sent to investors on Friday morning. WallachBeth Capital currently has a buy rating on the stock. In related news, Director ...
 WKRB News2 weeks ago WallachBeth Capital Raises Akorn Inc. (AKRX) Price Target to $40.00  Mideast Time2 weeks ago
Zolmax News

Vivus Inc. (VVUS) PT Set at $2.80 by WallachBeth Capital

Vivus Inc. (NASDAQ:VVUS) received a $2.80 target price from research analysts at WallachBeth Capital in a research report issued to clients and investors on Monday. The brokerage presently has a a buy rating on the biopharmaceutical company's ...
 WKRB News1 month ago Vivus Inc. (VVUS) Given a $2.80 Price Target at WallachBeth Capital  American Banking News - Forex1 month ago

Amici Capital LLC Acquires 642,120 Shares of Otonomy Inc. (OTIC)

Amici Capital LLC increased its stake in shares of Otonomy Inc. (NASDAQ:OTIC) by 1,212.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 695,061 shares of the ...
 Mideast Time1 month ago Otonomy Inc (OTIC) Shares Sold by Tiverton Asset Management LLC  WKRB News1 month ago
American Banking News

Chardan Capital Reiterates Buy Rating for uniQure NV (QURE)

uniQure NV (NASDAQ:QURE) s stock had its buy rating reissued by research analysts at Chardan Capital in a research report issued on Monday. A number of large investors recently made changes to their positions in the stock. Acadian Asset Management ...
 WKRB News1 month ago Sucampo Pharmaceuticals (SCMP) Buy Rating Reiterated at Roth Capital  American Banking News - Earnings1 month ago Sucampo Pharmaceuticals Inc. (SCMP) Given Buy Rating at Roth Capital  WKRB News1 month ago Impax Laboratories (IPXL) Overweight Rating Reiterated at Piper Jaffray Cos.  American Banking News2 weeks ago

uniQure NV (QURE) PT Set at $35.00 by Chardan Capital

uniQure NV (NASDAQ:QURE) Other equities analysts have also issued research reports about the stock. Leerink Swann reaffirmed a buy rating on shares of uniQure NV in a report on Sunday, June 12th. Cowen and Company reissued a buy rating on shares ...
 Mideast Time3 weeks ago uniQure NV (QURE) Given a $35.00 Price Target by Chardan Capital Analysts  WKRB News1 month ago Chardan Capital Analysts Give uniQure NV (QURE) a $35.00 Price Target  American Banking News - Forex1 month ago Spark Investment Management LLC Has $3,516,000 Stake in Uniqure NV (QURE)  WKRB News2 months ago
American Banking News - Earnings

Investment Analysts Price Target Changes for August, 10th (ALQA, CAR, CECE, DIS, FLO, FSLR, IOTS, IPXL, JAZZ, MRNS)

Investment Analysts price target changes for Wednesday, August 10th: Alliqua (NASDAQ:ALQA) had its target price cut by HC Wainwright from $4.00 to $2.50. They currently have a buy rating on the stock. Avis Budget Group (NASDAQ:CAR) had its target ...
 American Banking News - Earnings2 weeks ago Weekly Analysts Ratings Changes for Esperion Therapeutics (ESPR)  SleekMoney1 month ago
Pensions and Investments Online

Commodities have some investors saying no

Institutional investors are wondering whether investing in commodities is worth the trouble, as the asset class has suffered an annualized return of -6.46% in the 10 years through June 30. Indeed, the Bloomberg Commodity index has been negative ...
 Pensions and Investments Online1 month ago

Dow Extends Record Streak as U.S. Stocks Post Weekly Gains

Many investors said this week marked a decisive turnaround for risky assets, which had fallen sharply after the U.K. voted to leave the European Union on June 23. U.S. stocks surged on expectations that central banks would extend a period of low ...
 Nasdaq1 month ago U.S. Stocks Slip After Record Streak  Nasdaq1 month ago U.S. Stocks Waver After Record Streak  Nasdaq1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - wallachbeth capital llc
Get updated on latest news & your favorite topics right in your inbox!
More     Less